Literature DB >> 2297194

Abdominal obesity and breast cancer risk.

D V Schapira1, N B Kumar, G H Lyman, C E Cox.   

Abstract

STUDY
OBJECTIVE: To determine if body fat distribution affects breast cancer risk.
DESIGN: Prospective case-control study. PATIENTS: The anthropometric measurements of 216 consecutively and newly diagnosed women with invasive carcinoma of the breast were compared with those of 432 age-matched controls. The anthropometric measurements taken were abdomen, thigh, suprailiac, biceps, triceps, subscapular, and midaxillary skinfolds; waist and hip circumference; and weight and height. Women between 25 and 83 years of age were included in the study.
RESULTS: Patients with breast cancer had a significantly greater waist:hip circumference ratio than controls (P less than 0.001) and a significantly greater suprailiac:thigh skinfold ratio (P less than 0.001). The relative risk for breast cancer increased with increasing waist:hip circumference ratio (less than 0.73 = 1.00; 0.73 to 76 = 1.90; 0.77 to 0.80 = 2.83; greater than 0.80 = 6.46) and with suprailiac:thigh skinfold ratio (less than 0.42 = 1.00; 0.42 to 0.56 = 1.85; 0.57 to 0.71 = 2.25; greater than 0.71 = 5.85). At other sites of upper body obesity, such as the biceps and triceps, skinfolds were significantly greater in patients with breast cancer.
CONCLUSION: Although obese women are at slightly higher risk for developing breast cancer, women with android obesity are a segment of obese women who appear to be at a significantly higher risk for developing breast cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2297194     DOI: 10.7326/0003-4819-112-3-182

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  30 in total

Review 1.  Breast cancer hypothesis: a single cause for the majority of cases.

Authors:  R A Wiseman
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

Review 2.  Nutrition and survival after the diagnosis of breast cancer: a review of the evidence.

Authors:  Cheryl L Rock; Wendy Demark-Wahnefried
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

3.  Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels.

Authors:  B Marti; J Tuomilehto; V Salomaa; L Kartovaara; H J Korhonen; P Pietinen
Journal:  J Epidemiol Community Health       Date:  1991-06       Impact factor: 3.710

4.  Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

Authors:  Douglas A Corley
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

Review 5.  Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Authors:  Mark F Munsell; Brian L Sprague; Donald A Berry; Gary Chisholm; Amy Trentham-Dietz
Journal:  Epidemiol Rev       Date:  2014       Impact factor: 6.222

6.  Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project.

Authors:  I den Tonkelaar; F de Waard; J C Seidell; J Fracheboud
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

Review 7.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

8.  Fatty metamorphosis of the liver in patients with breast cancer: possible associated factors.

Authors:  Cheng-Hsin Chu; Shee-Chan Lin; Shou-Chuan Shih; Chin-Roa Kao; Sun-Yen Chou
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 9.  Phytoestrogens, body composition, and breast cancer.

Authors:  P L Horn-Ross
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

Review 10.  Associations between physical activity and susceptibility to cancer: possible mechanisms.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1998-11       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.